Front Runners: BioTelemetry (BEAT), Outerwall Inc. (OUTR), Amicus Therapeutics, Inc. (FOLD), Five Prime Therapeutics (FPRX), Apple (AAPL)

In a report published Monday, analysts at Avondale upgraded their rating on the shares of BioTelemetry, Inc. (BEAT) to ‘Market Perform’. The target price has been set to $15.00 from $8.00. BioTelemetry’s shares closed at $8.11 Friday. Avondale’s target price suggests a potential upside of about 72% from the name’s current price. BioTelemetry, Inc. (BEAT) […] View the full post at: Front Runners: BioTelemetry (BEAT), Outerwall Inc. (OUTR), Amicus Therapeutics, Inc. (FOLD), Five Prime Therapeutics (FPRX), Apple (AAPL) Related posts: Tellabs Soars on a Convincing Beat and Raise Apple’s Steve Jobs named world’s most valuable CEO Apple iPad Sales Hit 1 Million Just 28 Days After its Introduction